Skip to main content
. 2023 Mar 6;11:e14950. doi: 10.7717/peerj.14950

Table 2. Clinical demographic data of BAV and DCM patients.

Characteristics Patients with BAV & calcification Patients with DCM P value
Patients (n) 22 17
Age (y) 50.55 44.53
Gender, Male (%) 15 (68.2%) 12 (70.6%) 0.872
Risk Factors
Hypertension 5 (22.7%) 2 (11.8%) 0.376
Hyperlipidaemia 4 (18.2%) 3 (17.6%) 0.966
Diabetes mellites 1 (4.5%) 0 (0%) 0.373
Valvular dysfunction (aortic/mitral) 22 (100%) 6 (35.3%) 0
Hyperinflammatory responses (CRP/PCT) 4 (18.2%) 4 (23.5%) 0.682
ECG parameters
LVEF (%) 61.1 ± 1.58 28.2 ± 2.4 <0.0001
Transvalvular gradient (mmHg) 62.5 ± 30.4 0 <0.0001
Diameter of annulus (cm) 2.6 ± 0.4 2.0 ± 0.6 0.0006
Diameter of ascending aorta (cm) 4.6 ± 0.5 2.9 ± 0.4 <0.0001
Diameter of aortic sinus (cm) 4.2 ± 0.5 2.7 ± 0.6 <0.0001
Transvalvular velocity (m/s) 3.8 ± 1.0 1.4 ± 0.4 <0.0001
Medications
Statins 2 (9.1%) 1 (5.9%) 0.709
ACEI/ARB 3 (13.6%) 3 (17.6%) 0.731
β-blockers 5 (22.7%) 4 (23.5%) 0.953

Notes.

Data were shown as mean ± SD.

BAV
Bicuspid Aortic Valve
DCM
Dilated Cardiomyopathy
CRP
C-reactive protein
PCT
Procalcitonin
LVEF
Left Ventricular Ejection Fraction
ACEI
Angiotensin Converting Enzyme Inhibitor
ARB
Angiotensin Receptor Blocker